Article Text

Download PDFPDF

Is childhood obstructive sleep apnoea an independent risk factor of hypertension in adulthood?
Free
  1. Rosemary S C Horne1,
  2. Montida Veeravigrom2
  1. 1 Paediatrics, Monash University, Melbourne, Victoria, Australia
  2. 2 Pediatrics, Chulalongkorn University Faculty of Medicine, Bangkok, Thailand
  1. Correspondence to Professor Rosemary S C Horne; rosemary.horne{at}monash.edu

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Over a third of children snore when they are asleep and until the last decade this has been considered benign by both parents and health professionals. Snoring was considered something that children would simply grow out of. Snoring is the hallmark symptom of sleep-disordered breathing (SDB), which ranges in severity from simple or primary snoring to obstructive sleep apnoea (OSA) which affects up to 6% of children.1 The incidence of SDB peaks in the preschool years when the size of the adenoids and tonsils—the primary cause of paediatric SDB—peaks in relation to the bony skeleton. In addition, childhood obesity increases the risk of OSA, particularly in older children.

In adults, OSA is recognised as an independent risk factor for hypertension and reduced nocturnal dipping of blood pressure, both of which are associated with cardiovascular, cerebrovascular and end-stage renal disease.2 Recent studies in children have shown that blood pressure is elevated in primary school aged children with all severities of SDB, including primary snoring,3 and the beginnings of elevated blood pressure are evident in children with OSA as young as 3–5 years of age.4 Obesity compounds the adverse effects of OSA on the cardiovascular system.5

What has been lacking in the paediatric literature is knowledge of the long-term effects of SDB on blood pressure and whether childhood SDB is a determinant of adult blood pressure. The study by Chan et al addressed this important issue—following up 243 children recruited from the community at age 6–13 years over a 10-year period, into adolescence and adulthood. The study used the gold standard of polysomnography for determining SDB severity, in conjunction with 24-hour ambulatory blood pressure monitoring at both time points. The study found that those children with moderate-to-severe OSA at baseline had higher systolic blood pressure (average 6.5 mm Hg) and reduced nocturnal dipping (average 4%), when adjusted for age, sex, body mass index (BMI) and height at baseline, and the presence of OSA at follow-up. Overall, the study found that primary school aged children with moderate-to-severe OSA had a 2.5-fold increased risk of hypertension and 1.3-fold risk of reduced nocturnal dipping. These findings suggest that there is a threshold effect between childhood OSA and adult blood pressure, as only moderate-to-severe OSA was associated with adverse cardiovascular outcomes.

There is now evidence that any improvement in SDB severity lowers blood pressure, and this is more marked in children with a higher BMI.6 7 The study by Chan et al noted that many parents were reluctant for their child to undergo any treatment, as they perceived their child to be asymptomatic. Only 20% of children with OSA received surgical treatment and 14% medical treatment. A second paper from the same cohort of children reported that in 30% of children with OSA spontaneously resolved (obstructive apnoea–hypopnoea index <1 event/h).8 The 22% who continued to have OSA were predominantly male and had a higher BMI z-score at baseline. Furthermore, the study showed that more severe OSA in children older than 10 years of age tended to persist, while OSA diagnosed in younger children was less likely to correlate with persistence of OSA. The study highlights the urgent need to screen and treat all children for SDB as young as possible and importantly that older children and those who are overweight or obese require particular attention and follow-up to reduce the chances of OSA persisting into adulthood and increasing the risk of hypertension, cardiovascular, cerebrovascular disease and end-stage renal disease.

References

Footnotes

  • Contributors Both authors wrote and approved the editorial.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles